Brief: Calliditas Therapeutics AB Reports PDUFA Goal Date Extension For Nefecon NDA In U.S.
Sept 14 (Reuters) - Calliditas Therapeutics AB CALTX.ST :
* CALLIDITAS THERAPEUTICS AB CALTX.ST - PDUFA GOAL DATE
EXTENSION FOR NEFECON NDA IN U.S.
* CALLIDITAS THERAPEUTICS AB CALTX.ST - FDA HAS EXTENDED
PDUFA
GOAL DATE TO DECEMBER 15, 2021
* CALLIDITAS THERAPEUTICS AB -IN ITS REVIEW OF NDA, FDA HAS
REQUESTED FURTHER ANALYSES OF NEFLGARD TRIAL DATA WHICH CO HAS
PROVIDED TO FDA
Source text for Eikon: ID:nWkrc2FVBc
Further company coverage: CALTX.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Calliditas Therapeutics AB
See all newsBrief: Calliditas To Be Delisted From Nasdaq Stockholm
Brief: Calliditas Therapeutics Takes Certain Corporate Actions Following Announcement By Asahi Kasei
Brief: Asahi Kasei Corp: Notice Regarding Results Of Tender Offer For Shares Of Calliditas Therapeutics AB And Transfer Of Subsidiary
Calliditas Therapeutics AB reports results for the quarter ended in January - Earnings Summary
Brief: Calliditas Q2 Sales Beat Expectations